Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 21 | $15,061,285 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 02 May 2024 | Sale | 250 | 200.0981 | 50,025 | D |
02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 30 Apr 2024 | Sale | 250 | 204.135 | 51,034 | D |
01 May 2024 18:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 29 Apr 2024 | Sale | 2,439 | 204.329 | 498,358 | D |
03 Apr 2024 08:35 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 01 Apr 2024 | Sale | 6,477 | 217.29 | 1,407,387 | D |
03 Apr 2024 08:34 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 01 Apr 2024 | Sale | 3,500 | 217.29 | 760,515 | D |
29 Mar 2024 17:54 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 28 Mar 2024 | Sale | 3,553 | 216.74 | 770,077 | D |
11 Mar 2024 08:59 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 07 Mar 2024 | Sale | 5,048 | 218.45 | 1,102,736 | D |
11 Mar 2024 08:56 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 07 Mar 2024 | Sale | 227 | 218.45 | 49,588 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 1,553 | 217.9842 | 338,529 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 6,665 | 217.5205 | 1,449,774 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 7,907 | 215.6759 | 1,705,349 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 18,379 | 215.3661 | 3,958,214 | D |
22 Feb 2024 15:04 | LH | LABORATORY CORP OF AMERICA HOLDINGS | DIVINCENZO JONATHAN P. | EVP, Pres, Central Labs & Intl | 21 Feb 2024 | Sale | 500 | 215.4901 | 107,745 | D |
15 Feb 2024 08:32 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 13 Feb 2024 | Sale | 237 | 226.45 | 53,669 | D |
09 Feb 2024 12:19 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 08 Feb 2024 | Sale | 259 | 222.06 | 57,514 | D |
06 Feb 2024 15:47 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 05 Feb 2024 | Sale | 193 | 220.57 | 42,570 | D |
20 Nov 2023 12:23 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 16 Nov 2023 | Sale | 1,384 | 210.713 | 291,627 | D |
10 Aug 2023 08:55 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 08 Aug 2023 | Sale | 5,000 | 211.5665 | 1,057,832 | D |
03 Jul 2023 11:52 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 29 Jun 2023 | Sale | 212 | 240 | 50,880 | D |
23 May 2023 08:06 | LH | LABORATORY CORP OF AMERICA HOLDINGS | KIRCHGRABER PAUL R | CEO, Covance Drug Development | 19 May 2023 | Sale | 4,300 | 216.9086 | 932,707 | D |
22 May 2023 15:08 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 18 May 2023 | Sale | 1,500 | 216.77 | 325,155 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)